Playback speed
10 seconds
ASCO GI 2023 Phase Ib OBERTO-201 Study: Evaluating Safety, Tolerability, Immunogenicity, & Efficacy of Multiple Subcutaneous Injections of PolyPEPI1018 Vaccine as an Add-On IO to TAS-102 in Late-Stage MSS mCRC
By
ASCO GI 2023 Conference Coverage
FEATURING
Joleen Hubbard
By
ASCO GI 2023 Conference Coverage
FEATURING
Joleen Hubbard
43 views
February 3, 2023
Comments 0
Login to view comments.
Click here to Login
Recommended
AUTOPLAY